or Try an Advanced Search...

    Technical Analysis for SWTX - SpringWorks Therapeutics, Inc.

    Grade Last Price % Change Price Change
    F 38.04 3.17% 1.17
    SWTX closed up 3.17 percent on Friday, July 26, 2024, on 67 percent of normal volume. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.
    Earnings due: Aug 7
    *** please verify all earnings dates ***
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical SWTX trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    200 DMA Resistance Bearish 0.00%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
    Pocket Pivot Bullish Swing Setup 3.17%
    180 Bearish Setup Bearish Swing Setup 3.76%
    Inside Day Range Contraction 3.76%
    Inside Day Range Contraction 0.71%
    20 DMA Resistance Bearish 3.29%
    200 DMA Resistance Bearish 3.29%
    MACD Bearish Signal Line Cross Bearish 3.29%
    Older End-of-Day Signals for SWTX ...

       Recent Intraday Alerts

    Alert Time
    200 DMA Resistance about 8 hours ago
    20 DMA Resistance about 8 hours ago
    Rose Above 20 DMA about 8 hours ago
    Rose Above 200 DMA about 8 hours ago
    60 Minute Opening Range Breakout about 9 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    SWTX Chart by TradingView
    Basic chart:

    Profile

    Springworks Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It identifies pathways for drug development for patients with severe rare diseases and cancer. The firm's products include Nirogacestat, Mirdametinib and BGB-3245. The company was founded in August 2017 and is headquartered in Stamford, CT.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmacy Rare Diseases Drug Development

    Is SWTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jul 23 SpringWorks Therapeutics to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024
    Jul 1 SpringWorks Therapeutics Completes Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PN
    Jun 8 GSK, SpringWorks end collaboration agreement
    Jun 6 Insider Sale: Director Julie Hambleton Sells Shares of SpringWorks Therapeutics Inc (SWTX)
    Jun 6 Insider Sale: COO Badreddin Edris Sells 20,000 Shares of SpringWorks Therapeutics Inc (SWTX)
    Jun 6 Insider Sale: CEO Saqib Islam Sells 49,000 Shares of SpringWorks Therapeutics Inc (SWTX)
    Jun 5 SpringWorks Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
    May 23 SpringWorks Therapeutics Announces Data to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
    May 8 SpringWorks Therapeutics to Participate in the BofA Securities 2024 Health Care Conference
    May 5 SpringWorks Therapeutics, Inc. (SWTX) Q1 2024 Earnings Call Transcript
    See more SWTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 53.92
    52 Week Low 18.0
    Average Volume 766,375
    200-Day Moving Average 38.52
    50-Day Moving Average 39.44
    20-Day Moving Average 38.47
    10-Day Moving Average 38.30
    Average True Range 2.03
    RSI (14) 48.19
    ADX 18.47
    +DI 16.08
    -DI 17.84
    Chandelier Exit (Long, 3 ATRs) 36.71
    Chandelier Exit (Short, 3 ATRs) 41.26
    Upper Bollinger Bands 41.99
    Lower Bollinger Band 34.94
    Percent B (%b) 0.44
    BandWidth 18.31
    MACD Line -0.47
    MACD Signal Line -0.34
    MACD Histogram -0.1237
    Fundamentals Value
    Market Cap 2.74 Billion
    Num Shares 72.1 Million
    EPS -4.87
    Price-to-Earnings (P/E) Ratio -7.81
    Price-to-Sales 74.50
    Price-to-Book 8.55
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 40.95
    Resistance 3 (R3) 40.84 39.75 40.47
    Resistance 2 (R2) 39.75 39.01 39.81 40.30
    Resistance 1 (R1) 38.90 38.55 39.33 39.01 40.14
    Pivot Point 37.81 37.81 38.03 37.87 37.81
    Support 1 (S1) 36.96 37.07 37.39 37.07 35.94
    Support 2 (S2) 35.87 36.61 35.93 35.78
    Support 3 (S3) 35.02 35.87 35.62
    Support 4 (S4) 35.13